Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
Active, not recruiting · NCT05232929 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) | central nervous system disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy | Active, not recruiting | Phase 4 | 2026-09-09 | NCT05232929 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genentech, Inc. | 221 |
38 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.